BioNTech SE (22UA)
TG
Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Revenue | 108.59M | 482.33M | 18.98B | 17.31B | 3.82B |
Operating Income | -181.52M | -82.42M | 14.92B | 12.3B | 874.8M |
Pre Tax Income | -179.44M | -145.8M | 15.05B | 12.95B | 1.19B |
Net Income | -179.06M | 15.2M | 10.29B | 9.43B | 930.3M |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 |
Basic Earnings Per Share (EPS) | -0.771 | 0.062 | 42.44 | 39.661 | 3.913 |
EBIT | -181.52M | -82.42M | 14.92B | 12.3B | 874.8M |
EBITDA | -147.62M | -43.67M | 14.99B | 12.4B | 1.06B |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.